These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 7553293)

  • 1. Targeting urinary calcium oxalate crystallization with inulin-type AOFOS from Aspidopterys obcordata Hemsl. for the management of rat urolithiasis.
    Sun P; Yue J; Lu C; Ji K; Yang R; Lu J; Song X; Hu H; Zhao J; Yang Y; Xu Y
    J Ethnopharmacol; 2024 Jul; 329():118149. PubMed ID: 38580188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-urolithiasis activity and safety of strangury-relieving herbs: A comparative study based on fruit fly kidney stone model.
    Lu Y; Wu Z; Du Z; Lin X; Tian E; Zhang F; Chao Z
    J Ethnopharmacol; 2024 May; 326():117968. PubMed ID: 38428655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiurolithiatic Potential of Three Sri Lankan Medicinal Plants by the Inhibition of Nucleation, Growth, and Aggregation of Calcium Oxalate Crystals
    Hewagama SP; Hewawasam RP
    ScientificWorldJournal; 2022; 2022():8657249. PubMed ID: 35463824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiurolithic effects of medicinal plants: results of in vivo studies in rat models of calcium oxalate nephrolithiasis-a systematic review.
    Khan A; Bashir S; Khan SR
    Urolithiasis; 2021 Apr; 49(2):95-122. PubMed ID: 33484322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folium pyrrosiae ingestion has no effect on the thermodynamic or kinetic urinary risk factors for calcium oxalate urolithiasis in healthy subjects: a poor prognosis for alternative treatment in this type of stone former.
    Rodgers AL; Webber D; Ramsout R; Gohel MD
    Urolithiasis; 2015 Feb; 43(1):21-7. PubMed ID: 25238730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herbal preparations affect the kinetic factors of calcium oxalate crystallization in synthetic urine: implications for kidney stone therapy.
    Rodgers AL; Webber D; Ramsout R; Gohel MD
    Urolithiasis; 2014 Jun; 42(3):221-5. PubMed ID: 24648109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of Flos carthami extract against ethylene glycol-induced urolithiasis in rats.
    Lin WC; Lai MT; Chen HY; Ho CY; Man KM; Shen JL; Lee YJ; Tsai FJ; Chen YH; Chen WC
    Urol Res; 2012 Dec; 40(6):655-61. PubMed ID: 22398437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese medicine and the surgeon.
    Leung PC; Biji S; Yeung CK
    Chin J Integr Med; 2011 Jul; 17(7):548-55. PubMed ID: 21725883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Cystone® on urinary composition and stone formation over a one year period.
    Erickson SB; Vrtiska TJ; Lieske JC
    Phytomedicine; 2011 Jul; 18(10):863-7. PubMed ID: 21419609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystone® for 1 year did not change urine chemistry or decrease stone burden in cystine stone formers.
    Erickson SB; Vrtiska TJ; Canzanello VJ; Lieske JC
    Urol Res; 2011 Jun; 39(3):197-203. PubMed ID: 21161651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herbal medicines in the management of urolithiasis: alternative or complementary?
    Butterweck V; Khan SR
    Planta Med; 2009 Aug; 75(10):1095-103. PubMed ID: 19444769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chinese herbal medicines and their efficacy in treating renal stones.
    Gohel MD; Wong SP
    Urol Res; 2006 Dec; 34(6):365-72. PubMed ID: 16972062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of takusha and kagosou on calcium oxalate renal stones in rats].
    Yamaguchi S; Jihong L; Utsunomiya M; Yoshioka T; Okuyama A; Koide T; Sugiyama K
    Hinyokika Kiyo; 1995 Jun; 41(6):427-31. PubMed ID: 7645450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of chorei-to and gorei-san on calcium oxalate crystallization in human urine].
    Yoshimura K; Miyake O; Okuyama A; Yoshioka T; Honda M; Yamaguchi S; Koide T
    Hinyokika Kiyo; 1998 Jan; 44(1):13-6. PubMed ID: 9503201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of takusha, a kampo medicine, on renal stone formation and osteopontin expression in a rat urolithiasis model.
    Yasui T; Fujita K; Sato M; Sugimoto M; Iguchi M; Nomura S; Kohri K
    Urol Res; 1999 Jun; 27(3):194-9. PubMed ID: 10422821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of traditional Chinese medicine in the management of urinary stone disease.
    Miyaoka R; Monga M
    Int Braz J Urol; 2009; 35(4):396-405. PubMed ID: 19719854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effect of kampou extracts on in vitro calcium oxalate crystallization and in vivo stone formation in an animal model.
    Koide T; Yamaguchi S; Utsunomiya M; Yoshioka T; Sugiyama K
    Int J Urol; 1995 May; 2(2):81-6. PubMed ID: 7553293
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.